Search results
McGinn Penninger Investment Management Inc. Sells 365 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 21 hours agoMcGinn Penninger Investment Management Inc. decreased its holdings in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 1.8% in the 4th quarter, according to its most recent Form 13F filing ...
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
Morningstar· 6 days agoJohnson & Johnson (NYSE: JNJ) announced today that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies ...
Marathon Capital Management Has $4.48 Million Holdings in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 2 days agoMarathon Capital Management grew its stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 0.6% during the fourth quarter, according to the company in its most recent disclosure with ...
Johnson & Johnson (NYSE:JNJ) Shares Acquired by Jump Financial LLC
ETF DAILY NEWS· 7 days agoJump Financial LLC boosted its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 1,306.8% in the fourth quarter, according to the company in its most recent 13F filing with ...
Study links talc use to ovarian cancer — a potential boon for thousands suing J&J
NBC NEWS· 4 days agoNew research published this week lends credence to the more than 50,000 lawsuits against Johnson &...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoSAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives